Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer

Japanese Journal of Clinical Oncology

Volumn 42, Issue 9, 2012, Pages 845-850

  Kido, Hidenori ^a   Morizane, Chigusa ^a   Tamura, Tetsutaro ^a   Hagihara, Atsushi ^a   Kondo, Shunsuke ^a   Ueno, Hideki ^a   Okusaka, Takuji ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemotherapy; Gemcitabine; Pericardial effusion; Pleural effusion

Indexed keywords

GEMCITABINE;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FACE EDEMA; FATIGUE; FEMALE; FOLLOW UP; HEART TAMPONADE; HUMAN; LEG EDEMA; LYMPH NODE METASTASIS; NAUSEA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PLEURA EFFUSION;

ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PERICARDIAL EFFUSION; PLEURAL EFFUSION;

EID: 84865549150     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys099     Document Type: Article

References (20)

1. Ohtani Y, Sumi Y, Hisauchi K, et al. Procainamide-induced lupus in a patient with bilateral effusion. Nihon Kokyuki Gakkai Zassi 1998;36:535-40.
2. Ghose MK. Pericardial tamponade. A presenting manifestation of procainamide-induced lupus erythematosus. Am J Med 1975;58:581-5.
3. Carey RM, Coleman M. Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med 1973;54:84-7.
4. Bass BH. Hydralazine lung. Thorax 1981;36:695-6.
5. Varenika V, Blanc PD. A patient on RIPE therapy presenting with recurrent isoniazid-associated pleural effusions: a case report. J Med Case Reports 2011;5:558.
6. Siddiqui MA, Khan IA. Isoniazid-induced lupus erythematosus presenting with cardiac tamponade. Am J Ther 2002;9:163-5.
7. Webb DB, Whale RJ. Pleuropericardial effusion associated with minoxidil administration. Postgrad Med J 1982;58:319-20.
8. Kelly K, Swords R, Mahalingam D, Padmanabban S, Giles FJ. Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors. Targ Oncol 2009;4:99-105.
9. Breccia M, D'elia GM, D'Andrea M, et al. Pleuralpericardic effusion as uncommon complication in CML patients treated with Imatinib. Eur J Haematol 2005;74:89-90.
10. Vogl DT, Glatstein E, Carver JR, et al. Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leuk Lymphoma 2005;46:1313-20.
11. Vincenzi B, Santani D, Frezza AM, Rocci L, Tonini G. Docetaxel induced pericardial effusion. J Exp Clin Cancer Res 2007;26:417-20.
12. Semb KA, Aamdal S, Oian P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 1998;16:3426-32.
13. De Pas T, Curigliano G, Franceschelli L, et al. Gemcitabine-induced systemic capillary leak syndrome. Ann Oncol 2001;12:1651-2.
14. Baron D, Mayo A, Kluger Y. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease. Clin Oncol (R Coll Radiol) 2006;18:90-1.
15. Biswas S, Nik S, Corrie PG. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clin Oncol (R Coll Radiol) 2004;16:577-9.
16. Piccart MJ, Klijn J, Paridaens R, Nooil M, et al. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. J Clin Oncol 1997;15:3149-55.
17. Joerger M, Gunz A, Speich R, et al. Gemcitabine-related pulmonary toxicity. Swiss Med Wkly 2002;132:17-20.
18. Belknap SM, Kuzel TM, Yarnold PR. Clinical features and correlates of gemcitabine-associated lung injury. Cancer 2006;106:2051-7.
19. Sherrod AM, Brufsky A, Puhalla S. A case of late-onset gemcitabine lung toxicity. Oncology 2011;5:171-6.
20. Davidoff S, Shah RD, Arunabh T. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate. Respir Med 2006;100:760-3.